<p>DNB Asset Management AS 在最近向证券交易委员会（SEC）提交的 13F 文件中披露，在第四季度将其在 CVS Health Corporation（纽约证券交易所代码：CVS - 免费报告）的持股增加了 17.6%。该公司在季度内额外购买了 66,953 股后，持有 446,843 股该药房运营商的股票。根据其最近的 SEC 文件，DNB Asset Management AS 在 CVS Health 的持股价值为 35,461,000 美元。</p>
<ul>
<li>3 只医疗保健股票将从这项重大法案中受益</li>
</ul>
<p>其他一些对冲基金和机构投资者最近也调整了对该公司的持股。先锋集团（Vanguard Group Inc.）在第四季度将其在 CVS Health 的持股增加了 1.5%。先锋集团目前持有 120,709,530 股该药房运营商的股票，价值 9,579,508,000 美元，在此期间又购买了 1,824,424 股。资本世界投资者（Capital World Investors）在第三季度将其在 CVS Health 的持股增加了 2.1%。资本世界投资者目前持有 68,382,158 股该药房运营商的股票，价值 5,155,380,000 美元，在此期间又购买了 1,419,575 股。州街公司（State Street Corp）在第三季度将其在 CVS Health 的持股增加了 0.3%。州街公司目前持有 58,938,286 股该药房运营商的股票，价值 4,443,357,000 美元，在此期间又购买了 149,701 股。资本国际投资者（Capital International Investors）在第三季度将其在 CVS Health 的持股增加了 1.1%。资本国际投资者目前持有 26,692,203 股该药房运营商的股票，价值 2,012,347,000 美元，在上个季度又购买了 302,499 股。最后，景顺（Invesco Ltd.）在第三季度将其在 CVS Health 的持股增加了 3.2%。景顺目前持有 24,293,058 股该药房运营商的股票，价值 1,831,454,000 美元，在上个季度又购买了 760,579 股。80.66% 的股票由对冲基金和其他机构投资者持有。</p>
<h2>CVS Health 的内部交易</h2>
<p>在其他新闻中，执行副总裁 Tilak Mandadi 于 5 月 8 日星期五出售了 69,551 股公司的股票。该股票以平均价格 89.58 美元出售，总交易额为 6,230,378.58 美元。出售完成后，该执行副总裁持有 10,133 股公司的股票，价值 907,714.14 美元。这代表其持股减少了 87.28%。该交易已在向证券交易委员会提交的文件中披露，文件可通过此链接获取。公司内部人士持有 0.85% 的公司股票。</p>
<h2>分析师设定新的价格目标</h2>
<ul>
<li>这只 ETF 证明医疗保健复苏是真实的</li>
</ul>
<p>多家券商最近对 CVS 发布了报告。TD Cowen 将 CVS Health 的股票目标价从 105.00 美元上调至 110.00 美元，并在 5 月 11 日的研究报告中给予该股票 “买入” 评级。Argus 将 CVS Health 的股票目标价从 90.00 美元上调至 104.00 美元，并在周四的研究报告中给予该股票 “买入” 评级。Leerink Partners 在 3 月 5 日的研究报告中重申了 “跑赢大盘” 评级，并对 CVS Health 的股票设定了 98.00 美元的目标价。华尔街 Zen 在 5 月 9 日的研究报告中将 CVS Health 的股票评级从 “持有” 上调至 “买入”。最后，桑福德·C·伯恩斯坦（Sanford C. Bernstein）在 5 月 12 日的研究报告中将 CVS Health 的股票目标价从 94.00 美元上调至 106.00 美元，并给予该股票 “跑赢大盘” 评级。22 位投资分析师对该股票给予了 “买入” 评级，4 位给予了 “持有” 评级。根据 MarketBeat 的数据，CVS Health 目前的平均评级为 “适度买入”，平均目标价为 98.08 美元。</p>
<p><strong>查看我们关于 CVS Health 的最新研究报告</strong></p>
<h2>CVS Health 的价格表现</h2>
<ul>
<li>CVS Health 收入增长，股息保持强劲</li>
</ul>
<p>CVS 周五开盘价为 95.95 美元。该公司的债务与股本比率为 0.78，速动比率为 0.66，流动比率为 0.87。该股票的市值为 1,224.2 亿美元，市盈率为 42.27，市盈增长比率为 0.94，贝塔值为 0.60。该公司的 50 日简单移动平均线为 78.71 美元，200 日简单移动平均线为 78.59 美元。CVS Health Corporation 的 52 周低点为 58.50 美元，52 周高点为 98.43 美元。</p>
<p>CVS Health（纽约证券交易所代码：CVS - 获取免费报告）最近于 5 月 6 日星期三发布了其财报。该药房运营商报告本季度每股收益（EPS）为 2.57 美元，超出市场共识预期的 2.21 美元，超出幅度为 0.36 美元。该公司本季度的收入为 1,004.3 亿美元，而分析师预期为 949.9 亿美元。CVS Health 的净利润率为 0.72%，股本回报率为 11.88%。该公司本季度的收入较去年同期增长了 6.2%。在去年同期，该公司每股收益为 2.25 美元。CVS Health 将其 2026 财年的指引设定为每股收益 7.300-7.500 美元。整体来看，分析师预测 CVS Health Corporation 本年度将发布每股收益 7.44 美元。</p>
<h2>CVS Health 宣布分红</h2>
<p>该公司最近还宣布了季度分红，于 5 月 4 日星期一支付。4 月 23 日的股东获得了每股 0.665 美元的分红。除息日期为 4 月 23 日。这代表每年 2.66 美元的分红，收益率为 2.8%。CVS Health 的分红支付比率目前为 117.18%。</p>
<h2>CVS Health 新闻摘要</h2>
<p>以下是本周影响 CVS Health 的主要新闻故事：</p>
<ul>
<li>积极情绪：摩根士丹利上调了对 CVS Health 的目标股价，并维持了增持评级，显示出对公司强于预期的季度业绩后进一步上涨的信心。摩根士丹利发布 CVS Health 的积极预测 NYSE: CVS 股价</li>
<li>积极情绪：Argus 也提高了对 CVS Health 的展望，进一步增加了分析师支持的浪潮，这可能帮助股价上涨。Argus 发布 CVS Health 的积极预测 NYSE: CVS 股价</li>
<li>积极情绪：CVS 最近公布了 2026 年第一季度的强劲财报，收入和调整后的每股收益均超出预期，这继续推动投资者对执行和估值的乐观情绪。以下是为什么 CVS Health (CVS) 是未来 10 年值得购买的便宜股票</li>
<li>积极情绪：CVS 与 WGU 推出了一项在线药学预科学位项目，以帮助建立更强大的药剂师人才管道，这一举措可能支持长期的人员和服务增长。CVS Health®与 WGU 在全国范围内推出在线药学预科学位项目</li>
<li>中性情绪：CVS 通过在破产法庭批准后出售 Omnicare 推进了其投资组合重组，这简化了业务并剔除了一个表现不佳的部门，但也确认了持续的重组。CVS 通过 Omnicare 出售和无人机推广重新聚焦核心健康平台</li>
<li>中性情绪：CVS 还强调了在罗德岛的社区和品牌建设举措，包括其经济影响报告和扩大 WIC 接受度，这对声誉有积极影响，但不太可能单独推动股价。CVS Health 在罗德岛的年度影响</li>
</ul>
<h2>CVS Health 公司简介</h2>
<p>(免费报告)</p>
<p>CVS Health Corporation 是一家多元化的医疗保健公司，运营着一个大型零售药房网络、药房福利管理服务和医疗解决方案。公司总部位于罗德岛的伍恩索克特，其根源可以追溯到 20 世纪 60 年代初，已发展成为一个综合提供处方药、非处方产品、临床服务和健康保险的供应商。其运营模式结合了零售药房位置和店内诊所与更广泛的药房和健康计划能力。</p>
<p>主要业务活动包括 CVS 药房零售业务、MinuteClinic 步入式医疗诊所和提供扩展临床服务的 HealthHUB 地点。</p>
<h2>进一步阅读</h2>
<ul>
<li>五只我们更看好的股票，胜过 CVS Health</li>
<li>如果油价持续上涨，值得拥有的三只股票</li>
<li>分析师青睐的三家关键航空航天组件制造商</li>
<li>Alphabet 的 Googlebook 将 Gemini AI 引入 PC 硬件</li>
<li>Peloton 股票在乐观财报后回吐涨幅</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资$1,000 在 CVS Health 吗？</h2>
<p>在考虑 CVS Health 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 CVS Health 并不在名单上。</p>
<p>虽然 CVS Health 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

西维斯

<p>DNB 资产管理公司在第四季度将其在 CVS Health Corporation 的持股增加了 17.6%，目前拥有 446,843 股，价值 3546 万美元。其他机构投资者也提高了他们的持股比例。分析师们为 CVS 设定了新的价格目标，许多人将其评级为 “买入”。CVS Health 的股票开盘价为 95.95 美元，市值为 1224.2 亿美元，市盈率为 42.27</p>

<p>DNB Asset Management AS lifted its holdings in CVS Health Corporation (NYSE:CVS - Free Report) by 17.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 446,843 shares of the pharmacy operator's stock after buying an additional 66,953 shares during the quarter. DNB Asset Management AS's holdings in CVS Health were worth $35,461,000 as of its most recent SEC filing.</p>
<div class="lb-trans"><p>DNB Asset Management AS 在最近向证券交易委员会（SEC）提交的 13F 文件中披露，在第四季度将其在 CVS Health Corporation（纽约证券交易所代码：CVS - 免费报告）的持股增加了 17.6%。该公司在季度内额外购买了 66,953 股后，持有 446,843 股该药房运营商的股票。根据其最近的 SEC 文件，DNB Asset Management AS 在 CVS Health 的持股价值为 35,461,000 美元。</p>
</div><ul>
<li>3 Healthcare Stocks Set to Benefit From the One Big Beautiful Bill</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只医疗保健股票将从这项重大法案中受益</li>
</ul>
</div><p>A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Vanguard Group Inc. grew its position in shares of CVS Health by 1.5% in the 4th quarter. Vanguard Group Inc. now owns 120,709,530 shares of the pharmacy operator's stock worth $9,579,508,000 after buying an additional 1,824,424 shares during the period. Capital World Investors grew its position in shares of CVS Health by 2.1% in the 3rd quarter. Capital World Investors now owns 68,382,158 shares of the pharmacy operator's stock worth $5,155,380,000 after buying an additional 1,419,575 shares during the period. State Street Corp grew its position in shares of CVS Health by 0.3% in the 3rd quarter. State Street Corp now owns 58,938,286 shares of the pharmacy operator's stock worth $4,443,357,000 after buying an additional 149,701 shares during the period. Capital International Investors boosted its stake in CVS Health by 1.1% in the 3rd quarter. Capital International Investors now owns 26,692,203 shares of the pharmacy operator's stock worth $2,012,347,000 after purchasing an additional 302,499 shares in the last quarter. Finally, Invesco Ltd. boosted its stake in CVS Health by 3.2% in the 3rd quarter. Invesco Ltd. now owns 24,293,058 shares of the pharmacy operator's stock worth $1,831,454,000 after purchasing an additional 760,579 shares in the last quarter. 80.66% of the stock is owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>其他一些对冲基金和机构投资者最近也调整了对该公司的持股。先锋集团（Vanguard Group Inc.）在第四季度将其在 CVS Health 的持股增加了 1.5%。先锋集团目前持有 120,709,530 股该药房运营商的股票，价值 9,579,508,000 美元，在此期间又购买了 1,824,424 股。资本世界投资者（Capital World Investors）在第三季度将其在 CVS Health 的持股增加了 2.1%。资本世界投资者目前持有 68,382,158 股该药房运营商的股票，价值 5,155,380,000 美元，在此期间又购买了 1,419,575 股。州街公司（State Street Corp）在第三季度将其在 CVS Health 的持股增加了 0.3%。州街公司目前持有 58,938,286 股该药房运营商的股票，价值 4,443,357,000 美元，在此期间又购买了 149,701 股。资本国际投资者（Capital International Investors）在第三季度将其在 CVS Health 的持股增加了 1.1%。资本国际投资者目前持有 26,692,203 股该药房运营商的股票，价值 2,012,347,000 美元，在上个季度又购买了 302,499 股。最后，景顺（Invesco Ltd.）在第三季度将其在 CVS Health 的持股增加了 3.2%。景顺目前持有 24,293,058 股该药房运营商的股票，价值 1,831,454,000 美元，在上个季度又购买了 760,579 股。80.66% 的股票由对冲基金和其他机构投资者持有。</p>
</div><h2>Insider Transactions at CVS Health</h2>
<div class="lb-trans"><h2>CVS Health 的内部交易</h2>
</div><p>In other news, EVP Tilak Mandadi sold 69,551 shares of the company's stock in a transaction dated Friday, May 8th. The shares were sold at an average price of $89.58, for a total transaction of $6,230,378.58. Following the completion of the sale, the executive vice president owned 10,133 shares of the company's stock, valued at $907,714.14. This represents a 87.28% decrease in their position. The transaction was disclosed in a document filed with the Securities &amp; Exchange Commission, which is available through this link. Corporate insiders own 0.85% of the company's stock.</p>
<div class="lb-trans"><p>在其他新闻中，执行副总裁 Tilak Mandadi 于 5 月 8 日星期五出售了 69,551 股公司的股票。该股票以平均价格 89.58 美元出售，总交易额为 6,230,378.58 美元。出售完成后，该执行副总裁持有 10,133 股公司的股票，价值 907,714.14 美元。这代表其持股减少了 87.28%。该交易已在向证券交易委员会提交的文件中披露，文件可通过此链接获取。公司内部人士持有 0.85% 的公司股票。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析师设定新的价格目标</h2>
</div><ul>
<li>This ETF Is Proof That the Healthcare Rebound Is Real</li>
</ul>
<div class="lb-trans"><ul>
<li>这只 ETF 证明医疗保健复苏是真实的</li>
</ul>
</div><p>A number of brokerages recently issued reports on CVS. TD Cowen upped their price target on shares of CVS Health from $105.00 to $110.00 and gave the stock a &#34;buy&#34; rating in a research note on Monday, May 11th. Argus upped their price target on shares of CVS Health from $90.00 to $104.00 and gave the stock a &#34;buy&#34; rating in a research note on Thursday. Leerink Partners reiterated an &#34;outperform&#34; rating and issued a $98.00 price target on shares of CVS Health in a research note on Thursday, March 5th. Wall Street Zen upgraded shares of CVS Health from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a research note on Saturday, May 9th. Finally, Sanford C. Bernstein upped their price target on shares of CVS Health from $94.00 to $106.00 and gave the stock an &#34;outperform&#34; rating in a research note on Tuesday, May 12th. Twenty-two investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company's stock. According to data from MarketBeat, CVS Health presently has an average rating of &#34;Moderate Buy&#34; and an average price target of $98.08.</p>
<div class="lb-trans"><p>多家券商最近对 CVS 发布了报告。TD Cowen 将 CVS Health 的股票目标价从 105.00 美元上调至 110.00 美元，并在 5 月 11 日的研究报告中给予该股票 “买入” 评级。Argus 将 CVS Health 的股票目标价从 90.00 美元上调至 104.00 美元，并在周四的研究报告中给予该股票 “买入” 评级。Leerink Partners 在 3 月 5 日的研究报告中重申了 “跑赢大盘” 评级，并对 CVS Health 的股票设定了 98.00 美元的目标价。华尔街 Zen 在 5 月 9 日的研究报告中将 CVS Health 的股票评级从 “持有” 上调至 “买入”。最后，桑福德·C·伯恩斯坦（Sanford C. Bernstein）在 5 月 12 日的研究报告中将 CVS Health 的股票目标价从 94.00 美元上调至 106.00 美元，并给予该股票 “跑赢大盘” 评级。22 位投资分析师对该股票给予了 “买入” 评级，4 位给予了 “持有” 评级。根据 MarketBeat 的数据，CVS Health 目前的平均评级为 “适度买入”，平均目标价为 98.08 美元。</p>
</div><p><strong>Check Out Our Latest Research Report on CVS Health</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 CVS Health 的最新研究报告</strong></p>
</div><h2>CVS Health Price Performance</h2>
<div class="lb-trans"><h2>CVS Health 的价格表现</h2>
</div><ul>
<li>CVS Health Gains as Revenue Grows, Dividend Remains Strong</li>
</ul>
<div class="lb-trans"><ul>
<li>CVS Health 收入增长，股息保持强劲</li>
</ul>
</div><p>CVS opened at $95.95 on Friday. The company has a debt-to-equity ratio of 0.78, a quick ratio of 0.66 and a current ratio of 0.87. The stock has a market capitalization of $122.42 billion, a P/E ratio of 42.27, a P/E/G ratio of 0.94 and a beta of 0.60. The company's 50-day simple moving average is $78.71 and its two-hundred day simple moving average is $78.59. CVS Health Corporation has a 52-week low of $58.50 and a 52-week high of $98.43.</p>
<div class="lb-trans"><p>CVS 周五开盘价为 95.95 美元。该公司的债务与股本比率为 0.78，速动比率为 0.66，流动比率为 0.87。该股票的市值为 1,224.2 亿美元，市盈率为 42.27，市盈增长比率为 0.94，贝塔值为 0.60。该公司的 50 日简单移动平均线为 78.71 美元，200 日简单移动平均线为 78.59 美元。CVS Health Corporation 的 52 周低点为 58.50 美元，52 周高点为 98.43 美元。</p>
</div><p>CVS Health (NYSE:CVS - Get Free Report) last posted its earnings results on Wednesday, May 6th. The pharmacy operator reported $2.57 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.21 by $0.36. The business had revenue of $100.43 billion for the quarter, compared to analysts' expectations of $94.99 billion. CVS Health had a net margin of 0.72% and a return on equity of 11.88%. The business's revenue for the quarter was up 6.2% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.25 EPS. CVS Health has set its FY 2026 guidance at 7.300-7.500 EPS. As a group, analysts predict that CVS Health Corporation will post 7.44 EPS for the current year.</p>
<div class="lb-trans"><p>CVS Health（纽约证券交易所代码：CVS - 获取免费报告）最近于 5 月 6 日星期三发布了其财报。该药房运营商报告本季度每股收益（EPS）为 2.57 美元，超出市场共识预期的 2.21 美元，超出幅度为 0.36 美元。该公司本季度的收入为 1,004.3 亿美元，而分析师预期为 949.9 亿美元。CVS Health 的净利润率为 0.72%，股本回报率为 11.88%。该公司本季度的收入较去年同期增长了 6.2%。在去年同期，该公司每股收益为 2.25 美元。CVS Health 将其 2026 财年的指引设定为每股收益 7.300-7.500 美元。整体来看，分析师预测 CVS Health Corporation 本年度将发布每股收益 7.44 美元。</p>
</div><h2>CVS Health Announces Dividend</h2>
<div class="lb-trans"><h2>CVS Health 宣布分红</h2>
</div><p>The business also recently announced a quarterly dividend, which was paid on Monday, May 4th. Shareholders of record on Thursday, April 23rd were paid a dividend of $0.665 per share. The ex-dividend date was Thursday, April 23rd. This represents a $2.66 annualized dividend and a yield of 2.8%. CVS Health's dividend payout ratio is currently 117.18%.</p>
<div class="lb-trans"><p>该公司最近还宣布了季度分红，于 5 月 4 日星期一支付。4 月 23 日的股东获得了每股 0.665 美元的分红。除息日期为 4 月 23 日。这代表每年 2.66 美元的分红，收益率为 2.8%。CVS Health 的分红支付比率目前为 117.18%。</p>
</div><h2>CVS Health News Summary</h2>
<div class="lb-trans"><h2>CVS Health 新闻摘要</h2>
</div><p>Here are the key news stories impacting CVS Health this week:</p>
<div class="lb-trans"><p>以下是本周影响 CVS Health 的主要新闻故事：</p>
</div><ul>
<li>Positive Sentiment: Morgan Stanley raised its price target on CVS Health and kept an overweight rating, signaling confidence in further upside after the company’s stronger-than-expected quarterly results. Morgan Stanley Issues Positive Forecast for CVS Health NYSE: CVS Stock Price</li>
<li>Positive Sentiment: Argus also lifted its outlook for CVS Health, adding to the wave of analyst support that may be helping shares move higher. Argus Issues Positive Forecast for CVS Health NYSE: CVS Stock Price</li>
<li>Positive Sentiment: CVS reported solid Q1 2026 earnings recently, beating estimates on both revenue and adjusted EPS, which continues to drive investor optimism about execution and valuation. Here is Why CVS Health (CVS) is One of the Cheap Stocks to Buy For the Next 10 Years</li>
<li>Positive Sentiment: CVS and WGU launched an online pre-pharmacy degree program to help build a stronger pharmacist pipeline, a move that could support long-term staffing and service growth. CVS Health® and WGU launch online pre-pharmacy degree program for future pharmacists nationwide</li>
<li>Neutral Sentiment: CVS advanced its portfolio reset by selling Omnicare after bankruptcy court approval, which simplifies the business and removes an underperforming unit, but also confirms ongoing restructuring. CVS Refocuses On Core Health Platform With Omnicare Sale And Drone Rollout</li>
<li>Neutral Sentiment: CVS also highlighted community and brand-building initiatives in Rhode Island, including its economic impact report and expanded WIC acceptance, which are positive for reputation but less likely to move the stock on their own. CVS Health’s Annual Impact in Rhode Island</li>
</ul>
<div class="lb-trans"><ul>
<li>积极情绪：摩根士丹利上调了对 CVS Health 的目标股价，并维持了增持评级，显示出对公司强于预期的季度业绩后进一步上涨的信心。摩根士丹利发布 CVS Health 的积极预测 NYSE: CVS 股价</li>
<li>积极情绪：Argus 也提高了对 CVS Health 的展望，进一步增加了分析师支持的浪潮，这可能帮助股价上涨。Argus 发布 CVS Health 的积极预测 NYSE: CVS 股价</li>
<li>积极情绪：CVS 最近公布了 2026 年第一季度的强劲财报，收入和调整后的每股收益均超出预期，这继续推动投资者对执行和估值的乐观情绪。以下是为什么 CVS Health (CVS) 是未来 10 年值得购买的便宜股票</li>
<li>积极情绪：CVS 与 WGU 推出了一项在线药学预科学位项目，以帮助建立更强大的药剂师人才管道，这一举措可能支持长期的人员和服务增长。CVS Health®与 WGU 在全国范围内推出在线药学预科学位项目</li>
<li>中性情绪：CVS 通过在破产法庭批准后出售 Omnicare 推进了其投资组合重组，这简化了业务并剔除了一个表现不佳的部门，但也确认了持续的重组。CVS 通过 Omnicare 出售和无人机推广重新聚焦核心健康平台</li>
<li>中性情绪：CVS 还强调了在罗德岛的社区和品牌建设举措，包括其经济影响报告和扩大 WIC 接受度，这对声誉有积极影响，但不太可能单独推动股价。CVS Health 在罗德岛的年度影响</li>
</ul>
</div><h2>CVS Health Company Profile</h2>
<div class="lb-trans"><h2>CVS Health 公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免费报告)</p>
</div><p>CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.</p>
<div class="lb-trans"><p>CVS Health Corporation 是一家多元化的医疗保健公司，运营着一个大型零售药房网络、药房福利管理服务和医疗解决方案。公司总部位于罗德岛的伍恩索克特，其根源可以追溯到 20 世纪 60 年代初，已发展成为一个综合提供处方药、非处方产品、临床服务和健康保险的供应商。其运营模式结合了零售药房位置和店内诊所与更广泛的药房和健康计划能力。</p>
</div><p>Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.</p>
<div class="lb-trans"><p>主要业务活动包括 CVS 药房零售业务、MinuteClinic 步入式医疗诊所和提供扩展临床服务的 HealthHUB 地点。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than CVS Health</li>
<li>3 Stocks to Own If Gas Prices Keep Rising</li>
<li>3 Crucial Aerospace Component Makers That Analysts Love</li>
<li>Alphabet's Googlebook Brings Gemini AI to PC Hardware</li>
<li>Peloton Stock Gives Back Gains After Upbeat Earnings Report</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 CVS Health</li>
<li>如果油价持续上涨，值得拥有的三只股票</li>
<li>分析师青睐的三家关键航空航天组件制造商</li>
<li>Alphabet 的 Googlebook 将 Gemini AI 引入 PC 硬件</li>
<li>Peloton 股票在乐观财报后回吐涨幅</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=CVS"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in CVS Health Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资$1,000 在 CVS Health 吗？</h2>
</div><p>Before you consider CVS Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 CVS Health 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 CVS Health 并不在名单上。</p>
</div><p>While CVS Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 CVS Health 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

DNB Asset Management AS Grows Holdings in CVS Health Corporation $CVS

DNB 资产管理公司增持了 CVS Health Corporation 的股份 $CVS